David Mulham Mulham - 06 Feb 2023 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CHIEF SALES OFFICER
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
06 Feb 2023
Transactions value $
$0
Form type
4
Filing time
08 Feb 2023, 20:52:09 UTC
Previous filing
07 Feb 2023
Next filing
28 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1.56K +13.54% 13.1K 07 Feb 2023 Direct F1
transaction USNA Common Stock Options Exercise +1.68K +12.84% 14.7K 08 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Award $0 +9.51K +77.08% $0.00 21.8K 06 Feb 2023 Common Stock 9.51K Direct F1, F2
transaction USNA Restricted Stock Units Options Exercise $0 -1.56K -7.13% $0.00 20.3K 07 Feb 2023 Common Stock 1.56K Direct F1, F3
transaction USNA Restricted Stock Units Options Exercise $0 -1.68K -8.27% $0.00 18.6K 08 Feb 2023 Common Stock 1.68K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 On February 6th, 2023, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
F3 Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.
F4 Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.